[DPHARMA] QoQ Annualized Quarter Result on 30-Sep-2020 [#3]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
12-Nov-2020
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2020
Quarter
30-Sep-2020 [#3]
Profit Trend
QoQ- -0.04%
YoY- -1.9%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Revenue 643,786 665,816 569,902 581,088 604,088 634,852 576,462 7.64%
PBT 86,746 92,704 76,157 74,248 74,236 70,908 70,809 14.50%
Tax -20,738 -22,248 -17,547 -17,692 -17,656 -16,664 -15,536 21.25%
NP 66,008 70,456 58,610 56,556 56,580 54,244 55,273 12.57%
-
NP to SH 66,008 70,456 58,610 56,556 56,580 54,244 55,273 12.57%
-
Tax Rate 23.91% 24.00% 23.04% 23.83% 23.78% 23.50% 21.94% -
Total Cost 577,778 595,360 511,292 524,532 547,508 580,608 521,189 7.12%
-
Net Worth 614,350 635,424 642,484 584,565 581,725 540,662 525,364 11.00%
Dividend
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Div 7,061 - 45,891 4,639 6,843 - 40,937 -69.04%
Div Payout % 10.70% - 78.30% 8.20% 12.10% - 74.06% -
Equity
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Net Worth 614,350 635,424 642,484 584,565 581,725 540,662 525,364 11.00%
NOSH 706,330 706,026 706,026 706,026 684,383 684,383 684,383 2.12%
Ratio Analysis
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
NP Margin 10.25% 10.58% 10.28% 9.73% 9.37% 8.54% 9.59% -
ROE 10.74% 11.09% 9.12% 9.67% 9.73% 10.03% 10.52% -
Per Share
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
RPS 91.17 94.30 80.72 83.50 88.27 92.76 84.49 5.20%
EPS 9.34 9.96 8.46 8.21 8.26 7.92 8.25 8.63%
DPS 1.00 0.00 6.50 0.67 1.00 0.00 6.00 -69.74%
NAPS 0.87 0.90 0.91 0.84 0.85 0.79 0.77 8.48%
Adjusted Per Share Value based on latest NOSH - 706,026
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
RPS 66.93 69.22 59.24 60.41 62.80 66.00 59.93 7.64%
EPS 6.86 7.32 6.09 5.88 5.88 5.64 5.75 12.49%
DPS 0.73 0.00 4.77 0.48 0.71 0.00 4.26 -69.18%
NAPS 0.6387 0.6606 0.6679 0.6077 0.6047 0.5621 0.5461 11.01%
Price Multiplier on Financial Quarter End Date
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Date 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 -
Price 3.03 2.75 3.38 3.16 1.62 1.39 1.42 -
P/RPS 3.32 2.92 4.19 3.78 1.84 1.50 1.68 57.54%
P/EPS 32.41 27.56 40.72 38.88 19.60 17.54 17.53 50.69%
EY 3.09 3.63 2.46 2.57 5.10 5.70 5.70 -33.53%
DY 0.33 0.00 1.92 0.21 0.62 0.00 4.23 -81.77%
P/NAPS 3.48 3.06 3.71 3.76 1.91 1.76 1.84 52.99%
Price Multiplier on Announcement Date
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Date 17/08/21 03/05/21 22/02/21 12/11/20 13/08/20 18/05/20 13/02/20 -
Price 2.49 2.93 3.42 4.04 3.15 1.72 1.64 -
P/RPS 2.73 3.11 4.24 4.84 3.57 1.85 1.94 25.60%
P/EPS 26.64 29.36 41.20 49.71 38.10 21.70 20.24 20.12%
EY 3.75 3.41 2.43 2.01 2.62 4.61 4.94 -16.79%
DY 0.40 0.00 1.90 0.17 0.32 0.00 3.66 -77.17%
P/NAPS 2.86 3.26 3.76 4.81 3.71 2.18 2.13 21.73%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment